{"id":4730,"date":"2009-06-19T14:41:56","date_gmt":"2009-06-19T17:41:56","guid":{"rendered":"http:\/\/antonini.med.br\/blog\/?p=4730"},"modified":"2022-02-15T03:28:42","modified_gmt":"2022-02-15T03:28:42","slug":"linezolida","status":"publish","type":"post","link":"https:\/\/antonini.psc.br\/?p=4730","title":{"rendered":"Linezolida"},"content":{"rendered":"<p><!--more--><\/p>\n<p style=\"text-align: justify;\">RECOMENDA\u00c7\u00c3O<\/p>\n<p style=\"text-align: justify;\">Linezolida endovenosa j\u00e1 vem diluida, pronta para uso. N\u00e3o adicionar aditivos. Aplicar por infus\u00e3o intra-venosa por aproximadamente 30 a 120 minutos. N\u00e3o utilize bolsas de conex\u00f5es seriadas.<\/p>\n<p style=\"text-align: justify;\">INTRA-VENOSA EM &#8220;BOLO&#8221;<\/p>\n<p style=\"text-align: justify;\">N\u00e3o.<\/p>\n<p style=\"text-align: justify;\">PERFUS\u00c3O INTERMITENTE<\/p>\n<p style=\"text-align: justify;\">Sim. Aplicar por infus\u00e3o intra-venosa por aproximadamente 30 a 120 minutos<\/p>\n<p style=\"text-align: justify;\">INTRA-VENOSA CONT\u00cdNUA<\/p>\n<p style=\"text-align: justify;\">N\u00e3o.<\/p>\n<p style=\"text-align: justify;\">INTRAMUSCULAR<\/p>\n<p style=\"text-align: justify;\">N\u00e3o.<\/p>\n<p style=\"text-align: justify;\">SOLU\u00c7\u00d5ES COMPAT\u00cdVEIS<\/p>\n<p style=\"text-align: justify;\">Soro fisiol\u00f3gico.<\/p>\n<p style=\"text-align: justify;\">Soro glicosado 5%.<\/p>\n<p style=\"text-align: justify;\">Solu\u00e7\u00e3o de Ringer-lactato para inje\u00e7\u00e3o (Solu\u00e7\u00e3o de Hartmann para inje\u00e7\u00e3o).<\/p>\n<p style=\"text-align: justify;\">ESTABILIDADE<\/p>\n<p style=\"text-align: justify;\">Ap\u00f3s aberta a bolsa, utilizar imediatamente. N\u00e3o estocar a bolsa aberta nem sob refrigera\u00e7\u00e3o.<\/p>\n<p style=\"text-align: justify;\">OBSERVA\u00c7\u00d5ES<\/p>\n<p style=\"text-align: justify;\">As solu\u00e7\u00f5es de Linezolida cont\u00e9m a\u00e7ucar e devem ser utilizadas com cautela em diab\u00e9ticos.<\/p>\n<p style=\"text-align: justify;\">Fonte: Fresenius Kabi Norge AS<\/p>\n<p style=\"text-align: center;\">[ <a href=\"javascript:history.go(-1)\">Voltar<\/a> ]<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,27],"tags":[],"class_list":["post-4730","post","type-post","status-publish","format-standard","hentry","category-h-p","category-noticias"],"_links":{"self":[{"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/posts\/4730","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=4730"}],"version-history":[{"count":1,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/posts\/4730\/revisions"}],"predecessor-version":[{"id":26929,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=\/wp\/v2\/posts\/4730\/revisions\/26929"}],"wp:attachment":[{"href":"https:\/\/antonini.psc.br\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=4730"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=4730"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/antonini.psc.br\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=4730"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}